Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes
Open Access
- 4 March 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (3) , e242732
Abstract
Despite a high risk of opioid overdose in the first weeks after release from incarceration,1-6 most jails and prisons in the US do not routinely offer medications for opioid use disorder (MOUD) to patients during incarceration or upon release.7-11 The National Academy of Sciences, Engineering, and Medicine recommends that all forms of MOUD approved by the Food and Drug Administration (FDA) be available and accessible in all care venues, particularly carceral settings,12 and more jurisdictions have been adopting MOUD in recent years.13Keywords
This publication has 47 references indexed in Scilit:
- Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorderDrug and Alcohol Dependence, 2022
- Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest riskDrug and Alcohol Dependence, 2020
- Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient PreferenceCurrent Addiction Reports, 2019
- Judge denies employee claim of sexual harassmentNonprofit Business Advisor, 2019
- Implementing Opioid Agonist Treatment in Correctional FacilitiesJAMA Internal Medicine, 2018
- Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional SystemJAMA Psychiatry, 2018
- A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-releaseDrug and Alcohol Dependence, 2018
- A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-releaseDrug and Alcohol Dependence, 2017
- A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entryDrug and Alcohol Dependence, 2014
- Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide SurveyDrug and Alcohol Dependence, 2009